201 related articles for article (PubMed ID: 16573785)
1. Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy.
Huo TI; Huang YH; Lin HC; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
Am J Gastroenterol; 2006 May; 101(5):975-82. PubMed ID: 16573785
[TBL] [Abstract][Full Text] [Related]
2. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey.
Huo TI; Lin HC; Hsia CY; Wu JC; Lee PC; Chi CW; Lee SD
Am J Gastroenterol; 2007 Sep; 102(9):1920-30. PubMed ID: 17573792
[TBL] [Abstract][Full Text] [Related]
3. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
[TBL] [Abstract][Full Text] [Related]
4. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
5. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
6. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
[TBL] [Abstract][Full Text] [Related]
8. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee PC; Loong CC; Chiang JH; Huo TI; Lee SD
Cancer; 2010 Jun; 116(12):3006-14. PubMed ID: 20564406
[TBL] [Abstract][Full Text] [Related]
9. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
[TBL] [Abstract][Full Text] [Related]
10. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
13. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.
Kudo M; Chung H; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Hepatology; 2004 Dec; 40(6):1396-405. PubMed ID: 15565571
[TBL] [Abstract][Full Text] [Related]
14. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Farinati F; Rinaldi M; Gianni S; Naccarato R
Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
[TBL] [Abstract][Full Text] [Related]
16. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
Limquiaco JL; Wong GL; Wong VW; Lai PB; Chan HL
J Gastroenterol Hepatol; 2009 Jan; 24(1):63-9. PubMed ID: 19054256
[TBL] [Abstract][Full Text] [Related]
18. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program.
Ueno S; Tanabe G; Sako K; Hiwaki T; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
Hepatology; 2001 Sep; 34(3):529-34. PubMed ID: 11526539
[TBL] [Abstract][Full Text] [Related]
19. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
[TBL] [Abstract][Full Text] [Related]
20. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]